Spotify has begun removing hundreds of suspicious podcasts that were being used to promote and link to websites allegedly selling prescription medications without a valid prescription. The move comes in response to separate investigations by CNN and Business Insider that uncovered an alarming volume of such content—around 200 podcasts—some of which had remained on the platform for months.
These podcasts were typically short, often under a minute long, and offered little to no genuine audio content. Instead, they functioned primarily as digital storefronts, directing listeners to external websites that claimed to sell controlled substances like Adderall, Tramadol, Oxycodone, and Vicodin. The audio often featured synthetic, computerized voices reading out URLs or product claims, creating the appearance of a podcast while serving an entirely different purpose.
Business Insider reported that the episodes were designed more for promotion than storytelling, clearly prioritizing click-throughs to questionable pharmacies. CNN noted that some of these podcasts even appeared among the top 50 search results on the platform, raising questions about Spotify’s algorithmic recommendations and the effectiveness of its content moderation systems.
Spotify has since taken down much of the flagged material, but CNN said that as recently as last week, it was still able to find dozens of similar podcasts available for streaming. Some had remained on the platform for months, highlighting the challenge of proactive enforcement on a platform that hosts millions of audio uploads from around the world.
In response to the controversy, a Spotify spokesperson stated, “We are constantly working to detect and remove violating content across our service.” While the company emphasizes that it aims to democratize audio and welcome a range of voices, its platform rules explicitly prohibit the promotion of regulated or illegal goods—including unlicensed pharmaceuticals.
According to its published guidelines, Spotify bans content that facilitates the illicit sale of drugs, and the platform reserves the right to remove material that violates its terms or poses safety risks to users. However, the ease with which some of these podcasts remained live—despite their blatant violations—raises broader questions about the platform’s automated review systems and human moderation efforts.
This episode underscores the risks that come with an open podcast ecosystem, particularly one as large as Spotify’s. While giving creators a global platform remains central to the company’s mission, so too is the responsibility of ensuring that bad actors can’t exploit it for illegal activity. As streaming audio continues to grow in scale and influence, maintaining the integrity of the platform will likely require more proactive monitoring, stricter content review processes, and perhaps, a rethink of how algorithmic discovery functions in a space where abuse can be so easily disguised.
Spotify has not yet provided a detailed update on its ongoing efforts to fully remove the problematic content or prevent similar episodes from recurring.
